Accueil>>Signaling Pathways>> PROTAC>> E3 Ligase Ligand-Linker Conjugate>>E3 ligase Ligand-Linker Conjugates 49

E3 ligase Ligand-Linker Conjugates 49 (Synonyms: Cereblon Ligand-Linker Conjugates 14; E3 ligase Ligand-Linker Conjugates 49)

Catalog No.GC35956

Conjugués ligand-linker E3 ligase 49 est un conjugué ligand-linker E3 ligase synthétisé qui incorpore le ligand cereblon À base de pomalidomide et un linker utilisé dans la technologie PROTAC.

Products are for research use only. Not for human use. We do not sell to patients.

E3 ligase Ligand-Linker Conjugates 49 Chemical Structure

Cas No.: 2351103-63-2

Taille Prix Stock Qté
100mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire
1g Please Inquire Please Inquire
2g Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

E3 ligase Ligand-Linker Conjugates 49 incorporates a cereblon (CRBN) ligand for the E3 ubiquitin ligase, and a PROTAC linker. E3 ligase Ligand-Linker Conjugates 49 can be used to design PROTAC degrader. Cereblon

[1]. Zhou B, et al. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins withPicomolar Cellular Potencies and Capable of Achieving Tumor Regression. J Med Chem. 2018 Jan 25;61(2):462-481.

Avis

Review for E3 ligase Ligand-Linker Conjugates 49

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for E3 ligase Ligand-Linker Conjugates 49

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.